Rhumbline Advisers Accelerate Diagnostics, Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.64 - $1.03 $1,049 - $1,689	1,640 New	1,640 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.54 - $1.41 $19,312 - $50,425	-35,763 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.4 - $5.15 $940 - $3,460	-672 Reduced 1.84%	35,763 $51,000
Q4 2021 Feb 10, 2022	SELL	$4.27 - $6.97 $858 - $1,400	-201 Reduced 0.55%	36,435 $190,000
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $6,095 - $9,471	1,148 Added 3.23%	36,636 $214,000
Q2 2021 Aug 05, 2021	SELL	$6.81 - $9.23 $11,645 - $15,783	-1,710 Reduced 4.6%	35,488 $286,000
Q1 2021 May 06, 2021	SELL	$7.99 - $15.0 $14,142 - $26,550	-1,770 Reduced 4.54%	37,198 $309,000
Q4 2020 Feb 10, 2021	BUY	$7.04 - $11.7 $16,262 - $27,027	2,310 Added 6.3%	38,968 $295,000
Q3 2020 Nov 12, 2020	SELL	$9.98 - $18.04 $52,444 - $94,800	-5,255 Reduced 12.54%	36,658 $391,000
Q2 2020 Aug 13, 2020	BUY	$7.49 - $15.16 $35,922 - $72,707	4,796 Added 12.92%	41,913 $635,000
Q1 2020 May 06, 2020	BUY	$4.62 - $18.74 $965 - $3,916	209 Added 0.57%	37,117 $309,000
Q4 2019 Feb 05, 2020	BUY	$14.6 - $18.13 $3,839 - $4,768	263 Added 0.72%	36,908 $624,000
Q3 2019 Oct 23, 2019	BUY	$16.62 - $23.92 $7,013 - $10,094	422 Added 1.17%	36,645 $680,000
Q2 2019 Aug 14, 2019	BUY	$17.79 - $22.88 $26,133 - $33,610	1,469 Added 4.23%	36,223 $829,000
Q1 2019 May 01, 2019	SELL	$11.76 - $22.15 $4,633 - $8,727	-394 Reduced 1.12%	34,754 $731,000
Q4 2018 Jan 31, 2019	BUY	$10.42 - $21.94 $114,171 - $240,396	10,957 Added 45.29%	35,148 $404,000
Q3 2018 Nov 07, 2018	SELL	$20.4 - $24.6 $34,170 - $41,205	-1,675 Reduced 6.48%	24,191 $555,000
Q2 2018 Aug 06, 2018	BUY	$19.02 - $24.95 $9,700 - $12,724	510 Added 2.01%	25,866 $577,000
Q1 2018 May 02, 2018	SELL	$22.55 - $29.9 $16,461 - $21,827	-730 Reduced 2.8%	25,356 $579,000
Q4 2017 Feb 09, 2018	SELL	$18.0 - $30.0 $90,936 - $151,560	-5,052 Reduced 16.22%	26,086 $683,000
Q3 2017 Nov 06, 2017	BUY	$21.1 - $25.15 $657,011 - $783,120	31,138	31,138 $699,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account